Back to companies

Mezzion Pharma Co., Ltd.

140410KRKRX

메지온

Revenue
—
FY2024
Operating income
-₩14.3bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)